Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Central Nervous System Biomarkers Market to reach USD 8.35 billion by the end of 2029.

Global Central Nervous System Biomarkers Market Size study & Forecast, by Type (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers, Others) by Application (Drug Discovery and Development, Personalized Medicine, Other Applications), by End User (Diagnostic Labs, Clinics/Hospitals, Research Centers) and Regional Analysis, 2022-2029

Product Code: HLSMDE-28652073
Publish Date: 9-05-2023
Page: 200

Global Central Nervous System Biomarkers Market is valued approximately at USD 4.19 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.00% over the forecast period 2022-2029. A central nervous system (CNS) biomarker is a measurable substance or characteristic that provides information about the status or function of the central nervous system, which includes the brain and spinal cord. Biomarkers can include molecules such as proteins, metabolites, or genetic markers, as well as imaging or electrophysiological measurements. CNS biomarkers can be used for various purposes, such as diagnosing neurological disorders, monitoring disease progression, evaluating treatment efficacy, or predicting outcomes. The Central Nervous System Biomarkers market is expanding because of factors such as increasing incidences of neurological disorders and increasing research and development with successful clinical trials of biomarkers.

Growing prevelance of neurological disorders across the globe is fostering the market growth. According to report from Alzheimer Disease International Organization, in year 2020, globally there were around 55 million people suffering from dementia and this figure is expected to reach at 78 million in year 2030 and 139 million by year 2050. Additionally, there are more studies in the pipeline to create biomarkers for a variety of diseases, which is anticipated to accelerate the market expansion, For instance in year 2019, The University of Rochester and MC10 Inc. announced their partnership to explore new digital biomarkers for illnesses of the central nervous system. Along with these, increased development in genomics, proteomics, and imaging systems and burgeoning investments from the government and players is creating a lucrative market growth opportunity. However, high Cost of Central Nervous System Biomarkers may hamper the market growth.

The key regions considered for the Global Central Nervous System Biomarkers Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominates the market in terms of revenue, owing to the dominance of branded products and the region’s increasing disease prevalence. Whereas Asia Pacific is expected to grow with a fastest CAGR during the forecast period, owing to factors such as rising prevelance of neurological disorders, an increase in the number of collaborations for clinical trial, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market player included in this report are:
Acumen Pharmaceuticals Inc.
Alseres Pharmaceuticals Inc.
vacta Life Sciences Limited
Biomeriux (Banyan Biomarkers Inc.)
Bio-Rad Laboratories Inc.
G-Biosciences
Merck KGaA
Thermo Fisher Scientific Inc.
Eli Lilly and Company (Avid radiopharmaceuticals Inc.)
Proteome Sciences PLC (Service)

Recent Developments in the Market:
Ø In October 2021, Diadem announced the release of clinical data demonstrating that its AlzoSure biomarker test may forecast the course of Alzheimer’s disease years before symptoms manifest.
Ø In August 202, Johnson & Johnson Services, Inc. has partnered with Enigma Biomedical Group to research two novel neuroimaging biomarkers, JNJ-64413739 and JNJ-64511070, in an effort to better understand Alzheimer’s disease and other dementias.

Global Central Nervous System Biomarkers Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, Application, End User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Safety Biomarkers
Efficacy Biomarkers
Validation Biomarkers
Others

By Application:
Drug Discovery and Development
Personalized Medicine
Other Applications
By End User:
Diagnostic Labs
Clinics/Hospitals
Research Centers

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Central Nervous System Biomarkers Market, by region, 2019-2029 (USD Billion)
1.2.2. Central Nervous System Biomarkers Market, by Type, 2019-2029 (USD Billion)
1.2.3. Central Nervous System Biomarkers Market, by Application, 2019-2029 (USD Billion)
1.2.4. Central Nervous System Biomarkers Market, by End User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Central Nervous System Biomarkers Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Central Nervous System Biomarkers Market Dynamics
3.1. Central Nervous System Biomarkers Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of neurological disorders
3.1.1.2. Increasing Research and Development with Successful Clinical Trials of Biomarkers
3.1.2. Market Challenges
3.1.2.1. High Cost of Central Nervous System Biomarkers
3.1.3. Market Opportunities
3.1.3.1. Increased development in genomics, proteomics, and imaging systems
3.1.3.2. Burgeoning investments from the government and players
Chapter 4. Global Central Nervous System Biomarkers Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economic
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Central Nervous System Biomarkers Market, by Type
6.1. Market Snapshot
6.2. Global Central Nervous System Biomarkers Market by Type, Performance – Potential Analysis
6.3. Global Central Nervous System Biomarkers Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Central Nervous System Biomarkers Market, Sub Segment Analysis
6.4.1. Safety Biomarkers
6.4.2. Efficacy Biomarkers
6.4.3. Validation Biomarkers
6.4.4. Others
Chapter 7. Global Central Nervous System Biomarkers Market, by Application
7.1. Market Snapshot
7.2. Global Central Nervous System Biomarkers Market by Application, Performance – Potential Analysis
7.3. Global Central Nervous System Biomarkers Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
7.4. Central Nervous System Biomarkers Market, Sub Segment Analysis
7.4.1. Drug Discovery and Development
7.4.2. Personalized Medicine
7.4.3. Other Applications
Chapter 8. Global Central Nervous System Biomarkers Market, by End User
8.1. Market Snapshot
8.2. Global Central Nervous System Biomarkers Market by End User, Performance – Potential Analysis
8.3. Global Central Nervous System Biomarkers Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
8.4. Central Nervous System Biomarkers Market, Sub Segment Analysis
8.4.1. Diagnostic Labs
8.4.2. Clinics/Hospitals
8.4.3. Research Centers
Chapter 9. Global Central Nervous System Biomarkers Market, Regional Analysis
9.1. Central Nervous System Biomarkers Market, Regional Market Snapshot
9.2. North America Central Nervous System Biomarkers Market
9.2.1. U.S. Central Nervous System Biomarkers Market
9.2.1.1. Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Application breakdown estimates & forecasts, 2019-2029
9.2.1.3. End User breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Central Nervous System Biomarkers Market
9.3. Europe Central Nervous System Biomarkers Market Snapshot
9.3.1. U.K. Central Nervous System Biomarkers Market
9.3.2. Germany Central Nervous System Biomarkers Market
9.3.3. France Central Nervous System Biomarkers Market
9.3.4. Spain Central Nervous System Biomarkers Market
9.3.5. Italy Central Nervous System Biomarkers Market
9.3.6. Rest of Europe Central Nervous System Biomarkers Market
9.4. Asia-Pacific Central Nervous System Biomarkers Market Snapshot
9.4.1. China Central Nervous System Biomarkers Market
9.4.2. India Central Nervous System Biomarkers Market
9.4.3. Japan Central Nervous System Biomarkers Market
9.4.4. Australia Central Nervous System Biomarkers Market
9.4.5. South Korea Central Nervous System Biomarkers Market
9.4.6. Rest of Asia Pacific Central Nervous System Biomarkers Market
9.5. Latin America Central Nervous System Biomarkers Market Snapshot
9.5.1. Brazil Central Nervous System Biomarkers Market
9.5.2. Mexico Central Nervous System Biomarkers Market
9.5.3. Rest of Latin America Central Nervous System Biomarkers Market
9.6. Rest of The World Central Nervous System Biomarkers Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Acumen Pharmaceuticals Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Alseres Pharmaceuticals Inc.
10.2.3. vacta Life Sciences Limited
10.2.4. Biomeriux (Banyan Biomarkers Inc.)
10.2.5. Bio-Rad Laboratories Inc.
10.2.6. G-Biosciences
10.2.7. Merck KGaA
10.2.8. Thermo Fisher Scientific Inc.
10.2.9. Eli Lilly and Company (Avid radiopharmaceuticals Inc.)
10.2.10. Proteome Sciences PLC (Service)
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now